30Indexed trials
mesh condition
Breast Neoplasms
Intelligence
Breast Neoplasms intelligence: 30 indexed trials, 11 recruiting studies, 30 sponsors across 43 countries.
11Recruiting
30Sponsors
43Countries
Leading sponsors
Alliance Equiphoria10 recruiting
Centre Jean Perrin10 recruiting
Chinese PLA General Hospital11 recruiting
Duke University10 recruiting
Fox Chase Cancer Center10 recruiting
George Washington University11 recruiting
GlaxoSmithKline10 recruiting
H. Lee Moffitt Cancer Center and Research Institute11 recruiting
Hacettepe University10 recruiting
Indiana University10 recruiting
Institut Català d'Oncologia10 recruiting
Acibadem University10 recruiting
Geographic activity
United States14trials
France4trials
Spain4trials
Turkey (Türkiye)3trials
Belgium3trials
United Kingdom3trials
Germany3trials
Greece2trials
Poland2trials
Italy2trials
China2trials
Chile1trials
Leading interventions
Pain Neuroscience Education2trials
psychosocial assessment and care2trials
quality-of-life assessment2trials
'R' (Electro-kinetically altered beverage)1trials
Behavioural Graded Activity1trials
Biomedical Pain Education1trials
Behavioral, Psychological or Informational Intervention1trials
Capecitabine1trials
Carboplatin1trials
Control group1trials
Conventional therapy1trials
Body composition measurement1trials
Methodology note
This entity is derived from structured ClinicalTrials.gov conditions and/or MeSH normalization. Counts reflect the current NeuroRisk indexed corpus and are not guaranteed exhaustive global totals.